Related Experiment Video
Updated: May 16, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Cystatin C in children on chronic hemodialysis
Olivera Marsenic1, Andrea Wierenga, Donna R Wilson
1Pediatric Nephrology, Oklahoma University Health Sciences Center, 1200 N. Phillips Ave., Suite 14200, Oklahoma City, OK 73104, USA. oljamc@mac.com
Insights
Cystatin C (CyC) levels are high in pediatric hemodialysis (HD) patients and do not change with standard HD, suggesting extrarenal elimination. Residual renal function (RRF) does not impact CyC levels in these children.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Biomarkers
Background:
- Cystatin C (CyC) is a potential marker for middle-molecule accumulation, hemodialysis (HD) adequacy, and residual renal function (RRF).
- High CyC levels are linked to increased cardiovascular disease (CVD) risk.
- CyC kinetics in pediatric HD populations remain understudied.
Purpose of the Study:
- To investigate CyC kinetics in children undergoing HD.
- To determine the influence of RRF on CyC levels in pediatric HD patients.
Main Methods:
- Analysis of 21 HD sessions and 20 interdialytic periods in seven pediatric patients (age 5-19).
- Four patients were anuric (A), and three were non-anuric (NA).
- CyC measured pre- and post-HD, and before the subsequent HD session.
Main Results:
- No significant difference in CyC concentration pre- vs. post-HD (p=0.67) or between anuric and non-anuric groups.
- Weekly average pre-HD CyC correlated with age (r=0.808, p=0.03) and height (r=0.799, p=0.03).
- CyC levels did not correlate with RRF, single-pool Kt/V, ultrafiltration, HD duration, or blood processed.
Conclusions:
- Cystatin C is significantly elevated in pediatric HD patients.
- CyC remains at a steady state between HD sessions, indicating extrarenal elimination.
- Low RRF does not affect CyC elimination; levels increase with age and height.
Background:
Cystatin C (CyC) concentration has been suggested as a marker of middle-molecule accumulation, hemodialysis (HD) adequacy and for estimating residual renal function (RRF), but it has not been studied in pediatric HD. High CyC is associated with increased cardiovascular disease (CVD). We investigated CyC kinetics and the effect of RRF on CyC in a pediatric HD population.
Methods:
A total of 21 HD sessions and 20 interdialytic periods were analyzed in seven patients, age 5-19 years, of whom four were anuric (A) and three were non-anuric (NA). CyC was measured before (preHD) and after (postHD) three standard HD sessions in 1 week and prior to the first session of the following week.
Results:
We found no difference (p=0.67) in CyC concentration between preHD CyC (9.85 ± 2.15 mg/l; A vs. NA, p=0.37) and postHD CyC (10.04 ± 2.83 mg/l; A vs NA, p=0.28). The weekly average preHD CyC median concentration was 10.14 mg/l (A vs. NA, p=0.87) and correlated with age (r=0.808, p=0.03) and height measurement (r=0.799, p=0.03), but not with RRF, single-pool Kt/V, ultrafiltration, HD duration or blood liters processed.
Conclusions:
Cystatin C is very elevated in children on HD. It does not rise between HD sessions, is not removed by standard HD and remains at steady state; therefore, elimination is extrarenal. Low RRF does not affect CyC elimination. CyC increases with age and height. If a high CyC concentration can be proven to have a causative role in the development of CVD, routine intensified HD regimens in children may be indicated for its removal.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care

